These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 28543278)

  • 1. Panniculitis as the initial manifestation of dermatomyositis with anti-MDA5 antibody.
    Hasegawa A; Shimomura Y; Kibune N; Koshio J; Umemori Y; Abe R
    Clin Exp Dermatol; 2017 Jul; 42(5):551-553. PubMed ID: 28543278
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous Ulcerations in Anti-MDA5 Dermatomyositis.
    Charrow A; Vleugels RA
    N Engl J Med; 2019 Aug; 381(5):465. PubMed ID: 31365803
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dermatomyositis associated with anti-MDA5 autoantibody].
    Collado MV; Gargiulo MLÁ; Gómez R; Gómez G; Pérez N; Suarez L; Taratuto AL; Aruj P
    Medicina (B Aires); 2018; 78(5):360-363. PubMed ID: 30285929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-MDA5 antibody-positive hypomyopathic dermatomyositis complicated with pneumomediastinum.
    Yashiro M; Asano T; Sato S; Kobayashi H; Watanabe H; Miyata M; Migita K
    Fukushima J Med Sci; 2018; 64(2):89-94. PubMed ID: 30158335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimelanoma Differentiation-associated Gene 5 Dermatomyositis.
    Kurtzman DJB; Weinblatt M; Vleugels RA
    J Rheumatol; 2017 Jun; 44(6):850-851. PubMed ID: 28572474
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharyngeal ulceration and perforation: a rare manifestation in anti-MDA5 dermatomyositis.
    Luo L; Huang W; Ren F; Zhou J; Huang D; Tang L
    Rheumatology (Oxford); 2021 Apr; 60(4):e132-e133. PubMed ID: 33197245
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapidly progressive interstitial lung fibrosis in a patient with amyopathic dermatomyositis and anti‑MDA5 antibodies.
    Górka J; Szczeklik W; Włudarczyk A; Łoboda P; Chmura Ł; Musiał J
    Pol Arch Med Wewn; 2015; 125(9):685-6. PubMed ID: 26200801
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: A concise review with an emphasis on distinctive clinical features.
    Kurtzman DJB; Vleugels RA
    J Am Acad Dermatol; 2018 Apr; 78(4):776-785. PubMed ID: 29229575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-MDA-5 antibody-positive bullous dermatomyositis with palmar papules complicating rapidly progressive interstitial lung disease.
    Fujimoto N; Honda S; Wakabayashi M; Hamaguchi Y; Fujimoto M; Tanaka T
    Mod Rheumatol; 2016 Jul; 26(4):614-6. PubMed ID: 24842478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant activation of the type I interferon system may contribute to the pathogenesis of anti-melanoma differentiation-associated gene 5 dermatomyositis.
    Zhang SH; Zhao Y; Xie QB; Jiang Y; Wu YK; Yan B
    Br J Dermatol; 2019 May; 180(5):1090-1098. PubMed ID: 29947075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Painless Panniculitis upon the Treatment of Clinically Amyopathic Dermatomyositis with Anti-MDA5 Antibody.
    Kishida D; Ushiyama S; Shimojima Y; Ueno KI; Kurashina JI; Shirai T; Sekijima Y
    Intern Med; 2021 Aug; 60(16):2697-2700. PubMed ID: 33678748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myxovirus resistance protein 1-expressing fatal myocarditis in a patient with anti-MDA5 antibody-positive dermatomyositis.
    Sakamoto R; Kotobuki Y; Iga S; Nojima S; Deno R; Hanaoka Y; Tonomura K; Kiyohara E; Nakagawa Y; Ueda-Hayakawa I; Arase N; Fujimoto M
    Rheumatology (Oxford); 2021 Dec; 60(12):e450-e452. PubMed ID: 34382080
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-MDA-5-positive amyopathic dermatomyositis with cutaneous ulcerations.
    Chen Y; Teng GG; Teo WZ
    Med J Aust; 2021 Jul; 215(1):21-21.e1. PubMed ID: 34028032
    [No Abstract]   [Full Text] [Related]  

  • 14. MDA5
    Cassius C; Amode R; Delord M; Battistella M; Poirot J; How-Kit A; Lepelletier C; Jachiet M; de Masson A; Frumholtz L; Cordoliani F; Boccara D; Lehmann-Che J; Wong J; Dubanchet S; Alberdi AJ; Merandet M; Bagot M; Bensussan A; Bouaziz JD; Le Buanec H
    J Invest Dermatol; 2020 Jun; 140(6):1276-1279.e7. PubMed ID: 31955963
    [No Abstract]   [Full Text] [Related]  

  • 15. Three cases of Anti-MDA5 positive dermatomyositis with interstitial lung disease and pneumomediastium.
    Figueiredo C; Matos AL; Calvao J; Goncalo M
    Dermatol Online J; 2024 Mar; 30(1):. PubMed ID: 38762870
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-MDA5-Positive Dermatomyositis: A Description of the Cutaneous and Systemic Manifestations in 2 Cases.
    Barrientos N; Sicilia JJ; Moreno de Vega MJ; Dominguez JD
    Actas Dermosifiliogr (Engl Ed); 2018 Mar; 109(2):188-190. PubMed ID: 29162227
    [No Abstract]   [Full Text] [Related]  

  • 17. Bosentan for Cutaneous Ulcers in Anti-MDA5 Dermatomyositis.
    Combalia A; Giavedoni P; Tamez L; Grau-Junyent JM; Mascaró JM
    JAMA Dermatol; 2018 Mar; 154(3):371-373. PubMed ID: 29344607
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dermatomyositis associated with anti-MDA5 antibodies and pneumocystis pneumonia: Two lethal cases].
    Aymonier M; Abed S; Boyé T; Barazzutti H; Fournier B; Morand JJ
    Ann Dermatol Venereol; 2017 Apr; 144(4):279-283. PubMed ID: 27839728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease.
    Yoshida N; Okamoto M; Kaieda S; Fujimoto K; Ebata T; Tajiri M; Nakamura M; Tominaga M; Wakasugi D; Kawayama T; Kuwana M; Mimori T; Ida H; Hoshino T
    Respir Investig; 2017 Jan; 55(1):24-32. PubMed ID: 28012490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.